Cronos Group Inc (TSE: CRON) (NASDAQ: CRON) (FRA: 7CI) will be acquiring the top adult-use cannabis company in Europe. CanAdelaar has a dominant position in the Netherlands’ regulated “Wietexperiment” recreational pilot program — the largest operational adult-use market throughout the continent.
Cronos shares spiked Tuesday on the back of the announcement, clocking out 8.9 per cent higher than previous close on the Nasdaq at US$2.91. The stock rose by over 12 per cent at the intraday peak.
Cronos will be paying US$67 million in cash upfront for CanAdelaar. This will be proceeded by additional contingent payments determined by CanAdelaar’s performance in 2026 and 2027.
“We are excited to work with the Dutch government, regulators, coffee shops, adult consumers and all stakeholders to make the Wietexperiment a continued success,” said Cronos CEO Mike Gorenstein.
CanAdelaar stands out because of its vast cultivation space. At 540,000 square feet, it is the only industrial scale greenhouse operated by any of the 10 licensed providers involved in the pilot initiative. This facility is capable of producing 20,000 kilograms of dried flower per annum.
This substantial production yield has enabled CanAdelaar to keep all 72 pot shops involved in the Wietexperiment topped up with pre-rolled joints, buds, hashish, brownies and so on since 2023. This cultivation complex is at least 20 times larger than Leli Holland’s — an Amsterdam company involved in the pilot that Village Farms International Inc (NASDAQ: VFF) (FRA: 02V) recently took full ownership of.
Cronos will gain access to an emerging market with significant growth potential through the acquisition. The deal is anticipated to close early next year.
Many market observers consider Holland’s financial outlook to be much brighter than the United States or Canada at the moment. Licensed producers and investors in North America have grown tired of repeated federal rescheduling rumours that never materialize, problematic market conditions and high taxes north of the border.
Still, the acquisition carries regulatory risk. The Wietexperiment is not yet a permanent national framework, and future Dutch policy outcomes will determine whether the market can scale up. Competitive pressures and evolving European cannabis rules may also impact CanAdelaar’s long-term performance.
Cronos Group is entering the Netherlands via an acquisition of CanAdelaar B.V. for $67 million in cash. $CRON@CultivatedNews readers saw this coming: In Friday, I wrote a key takeaway from MJBiz is that Canadian cannabis firms are eyeing the EU. Expect more deals to come.…
— Jeremy Berke 🌱 (@jfberke) December 9, 2025
Read more: High Tide becomes first public North American cannabis operator to enter Germany
Follow Rowan Dunne on LinkedIn
rowan@mugglehead.com
